Press Releases

Simtra BioPharma Solutions is executing a bold, dual-continent expansion strategy to meet growing global demand for complex, high-value therapies.  

Simtra BioPharma Solutions announces the purchase from Cook Group of a 65-acre property with more than 300,000 square feet of available space for expansion under-roof near its existing manufacturing facility in Bloomington, Indiana.

Simtra announced today that it completed the construction of its new production manufacturing building at its campus in Halle, Germany.

Simtra BioPharma Solutions announced that it has formed a five-year strategic alliance with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada.

Simtra BioPharma Solutions announces the publication of its inaugural Sustainability Report for the year ended December 31, 2024.

Simtra BioPharma Solutions expands capabilities with $14M investment for accelerated development and manufacturing of antibody-drug conjugates (ADCs) as part of the scaling of its development services business.

Simtra BioPharma Solutions, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, is pleased to announce the appointment of Dr. Mike Schäfers, Ph.D., as Chief Commercial Officer and Head of Business Development.

Simtra BioPharma Solutions, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, is pleased to announce the appointment of Dr. Lidia Serina, Ph.D., as Head of Development Services.

Simtra BioPharma Solutions (Simtra), a premier injectable contract development and manufacturing organization (CDMO), today announced a $250+ million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana.